$CRNX Crinetics Pharmaceuticals, Inc. Insider Trading Week 28/2018

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Crinetics Pharmaceuticals, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in Crinetics Pharmaceuticals, Inc. in week 28/2018.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Option Exercise	C	0.00	61,861	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Option Exercise	C	0.00	383,507	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Option Exercise	C	0.00	1,484,690	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Option Exercise	C	0.00	9,204,220	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	P	17.00	4,600	78,200	139,969	135.4 K to 140 K (+3.40 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	P	17.00	110,400	1,876,800	3,359,309	3.2 M to 3.4 M (+3.40 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	C	0.00	18,802	0	135,369	116.6 K to 135.4 K (+16.13 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	C	0.00	116,567	0	116,567	0 to 116.6 K
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	C	0.00	451,274	0	3,248,909	2.8 M to 3.2 M (+16.13 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	5AM Ventures IV, L.P.	10% Owner	Buy	C	0.00	2,797,635	0	2,797,635	0 to 2.8 M
Jul 20 2018	CRNX	Crinetics Pharmace ...	PERCEPTIVE ADVISORS LLC	Director	Option Exercise	C	0.00	6,186,205	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	PERCEPTIVE ADVISORS LLC	Director	Buy	P	17.00	400,000	6,800,000	2,280,305	1.9 M to 2.3 M (+21.27 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	PERCEPTIVE ADVISORS LLC	Director	Buy	C	0.00	1,880,305	0	1,880,305	0 to 1.9 M
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Option Exercise	C	0.00	187,648	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Option Exercise	C	0.00	1,358,903	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Option Exercise	C	0.00	1,163,311	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Option Exercise	C	0.00	8,424,416	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Buy	P	20.73	153,180	3,175,421	294,357	141.2 K to 294.4 K (+108.50 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Buy	P	17.00	141,177	2,400,009	141,177	0 to 141.2 K
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Buy	P	17.00	7,137	121,329	417,762	410.6 K to 417.8 K (+1.74 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Buy	P	17.00	51,686	878,662	3,025,339	3 M to 3 M (+1.74 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Buy	C	0.00	57,035	0	410,625	353.6 K to 410.6 K (+16.13 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Buy	C	0.00	413,040	0	2,973,653	2.6 M to 3 M (+16.13 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Buy	C	0.00	353,590	0	353,590	0 to 353.6 K
Jul 20 2018	CRNX	Crinetics Pharmace ...	Vivo Capital VIII, LLC	10% Owner	Buy	C	0.00	2,560,613	0	2,560,613	0 to 2.6 M
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Option Exercise	C	0.00	103,293	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Option Exercise	C	0.00	45,192	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Option Exercise	C	0.00	40,826	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Option Exercise	C	0.00	1,357,240	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Option Exercise	C	0.00	640,332	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Option Exercise	C	0.00	280,485	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Option Exercise	C	0.00	253,091	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Option Exercise	C	0.00	8,413,817	0	0
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	C	0.00	31,396	0	226,025	194.6 K to 226 K (+16.13 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	C	0.00	13,736	0	98,989	85.3 K to 99 K (+16.11 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	C	0.00	12,409	0	89,336	76.9 K to 89.3 K (+16.13 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	C	0.00	412,534	0	2,969,926	2.6 M to 3 M (+16.13 %)
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	C	0.00	194,629	0	194,629	0 to 194.6 K
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	C	0.00	85,253	0	85,253	0 to 85.3 K
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	C	0.00	76,927	0	76,927	0 to 76.9 K
Jul 20 2018	CRNX	Crinetics Pharmace ...	Versant Venture Capital V, L.P ...	10% Owner	Buy	C	0.00	2,557,392	0	2,557,392	0 to 2.6 M
Jul 20 2018	CRNX	Crinetics Pharmace ...	Krasner Alan Seth	Chief Medical Offic ...	Buy	P	17.00	2,000	34,000	2,000	0 to 2 K